Carnosic acid is a strong dietary antioxidant derived from rosemary. Here, we have demonstrated that carnosic acid decreased viability of the human promyelocytic leukaemia cell line, HL-60, in dose-and time-dependent manners, and induced G 1 arrest and apoptosis. Carnosic acid also augmented these effects when induced by a low (physiological) concentration of arsenic trioxide, which was associated with upregulation of p27 and activation of caspase-9. These effects appeared to be mediated by the induction of phosphatase and tensin homologue (PTEN) expression. These findings indicate that PTEN plays an important role in the coordinated induction of apoptosis and G 1 arrest by carnosic acid and arsenic trioxide. Carnosic acid may have potential as an adjuvant in arsenic trioxide-induced apoptosis therapy due to its anticipated safety and great potency in enhancing the apoptosis-inducing action of a low concentration of arsenic trioxide.
Introduction
Acute myeloid leukaemia (AML) is an aggressive haematological malignancy. The development and progression of the leukaemic disease invariably involves deregulation in the apoptotic response; 1 therefore, apoptosis-inducing therapy is one of the current primary treatments for AML.
Arsenic trioxide (As 2 O 3 ), as an apoptosis inducer, has shown substantial efficacy in treating both newly diagnosed and relapsed/refractory patients with acute promyelocytic leukaemia (APL; a subset of AML). 2 The reported chronic toxicities and carcinogenicity of arsenic trioxide have, however, hampered its acceptance as a firstchoice drug. 3 One approach to overcome this problem is combination therapy, which may allow for administration of lower doses of arsenic trioxide, thereby minimizing toxicity and potential drug antagonism. 4 Thus, it is of great importance to develop adjuvant agents that, as well as having low toxicity, will increase the apoptotic action of arsenic trioxide and, thereby, enable dosages to be reduced to physiologically tolerable concentrations (< 5 µM). 4 Carnosic acid (Fig. 1) , the major polyphenol in rosemary (Rosmarinus officinalis L.) shows non-toxicity in human use, and exhibits high antioxidant activity in foods and biological systems. 5 Previous studies have shown that carnosic acid enhances the production of nerve growth factor in T98G human glioblastoma cells, 6 and inhibits proliferation and causes cell cycle block in Caco-2 human colonic adenocarcinoma cells. 7 Several groups have also reported that carnosic acid was able to induce differentiation of leukaemia cells in vitro 5, 8 and in vivo. 9 Meanwhile, there has been very little study undertaken on apoptosis induced by carnosic acid in human leukaemic cells. Recent studies have established a critical role for the dual lipid/protein phosphatase PTEN (phosphatase and tensin homologue deleted in chromosome 10) in tumour suppression. 10 The best elucidated function of PTEN is that, by using its lipid phosphatase activity to dephosphorylate phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ), PTEN negatively regulates the phosphoinositide-3-kinase (PI3K) -protein kinase B (PKB/Akt) pathway and, thus, leads to apoptosis and inhibition of tumour formation. 11 For this reason, PTEN, as a crucial tumour suppressor, represents a potential target for apoptosisinducing therapy.
The above mentioned considerations have prompted us to investigate the effects of carnosic acid on apoptosis of the human promyelocytic leukaemia cell line, HL-60.
Materials and methods

CELLS, CULTURE MEDIUM, CHEMICALS AND ANTIBODIES
The HL-60 cell line was obtained from the Shandong Academy of Medical Sciences, Jinan, China. They were cultured in suspension in RPMI 1640 medium supplemented with 10% fetal bovine serum at 37°C, in a humidified atmosphere of 5% CO 2 in air. The cultures were passaged two or three times weekly to maintain log-phase growth.
Carnosic acid, arsenic trioxide and MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) were purchased from Sigma Chemical Co., St Louis, MO, USA. Stock solutions of carnosic acid (10 mg/ml) and arsenic trioxide (1 mg/ml) were prepared in absolute ethanol. 
CELL CYCLE ANALYSIS
To evaluate whether carnosic acid could induce cell cycle arrest, cell cycle progression of HL-60 cells was examined. Cells were treated for 24 -48 h with carnosic acid (10, 15, 20 µM), and for up to 48 h with carnosic acid (15 µM), arsenic trioxide (4 µM) or a combination of carnosic acid (15 µM) plus arsenic trioxide (4 µM). Untreated cells were used as controls. Cells were then washed twice with ice-cold phosphate-buffered saline (PBS) and fixed in 70% ethanol at 4°C for 18 h. The fixed cells were then re-suspended in PBS and treated with 5 mg/ml ribonuclease A for 10 min. Finally, propidium iodide was added, followed by 30 min incubation at room temperature and then analysis by flow cytometry (FCM).
ANALYSIS OF APOPTOSIS
HL-60 cells were treated for up to 48 h with carnosic acid (10, 15, 20 µM), arsenic trioxide (4 µM) or a combination of carnosic acid (15 µM) plus arsenic trioxide (4 µM). Untreated cells were used as controls. Quantification of cell apoptosis was determined using the Annexin V-FITC kit, as per the manufacturer's instructions, and analysed by FCM. Quantitative assessment of apoptotic cells was also made by the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labelling (TUNEL) method. The BD ApoAlert™ DNA fragmentation assay was performed according to the user manual. Cells were analysed by FCM.
WESTERN BLOTTING
Cell extracts (50 µg of total protein) were resolved on sodium dodecyl sulphatepolyacrylamide gel electrophoresis and transferred electrophoretically to nitrocellulose membranes. The blots were blocked and incubated with primary antibody in primary antibody buffer (Tris-buffered saline Tween 20 with 0.2% low-fat milk powder). They were then incubated in 1/2000 horseradish peroxidase-conjugated secondary antibody in block buffer. The quality of loading and transfer was assessed by immunostaining with β-actin antibody.
REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION (RT-PCR)
Total RNA was extracted from 5 × 10 6 cells using TRIzol ® reagent according to the manufacturer's instructions. Total RNA (2 µg) was reverse transcribed to complementary DNA using Moloney murine leukaemia virus (M-MLV) reverse transcriptase and olig-dT, and amplified using deoxynucleotide and Taq polymerase. The primers were: PTEN (671 base pairs [bp]), 5′-GGA CGA ACT GGT GTA ATG ATA TG-3′ (sense), 5′-TCT ACT GTT TTT GTG AAG TAC AGC-3′ (antisense), and β-actin (271 bp), 5′-CTA CAA TGA GCT GCC TGT GGC-3′ (sense), 5′-CAG GTC CAG ACG CAG GAT R Wang, H Li, G Guo et al. Carnosic acid/arsenic trioxide in leukaemia cell apoptosis GGC-3′ (antisense). The PCR procedure consisted of an initial denaturation at 94°C for 3 min, followed by 30 cycles of 94°C for 1 min, 55°C for 1 min and 72°C for 1 min and, finally, 7 min at 72°C. All PCR products underwent electrophoresis in a 2% agarose gel containing ethidium bromide.
STATISTICAL ANALYSIS
All experiments were repeated at least three times. Results are expressed as the mean ± SD. Differences between groups were assessed using Student's t-test. A P-value < 0.05 was considered to be statistically significant.
Results
HL-60 CELL VIABILITY ASSAY
When HL-60 cells were incubated in the presence of increasing concentrations of carnosic acid (5 -25 µM) for 24 -72 h their viability was decreased in a dose-and timedependent manner ( Fig. 2A) . After 15 µM carnosic acid and 4 µM arsenic trioxide treatment for 48 h, cell viabilities were significantly reduced compared with the control to 87.1% and 72.8%, respectively (P < 0.05; Fig. 2B ). However, a further significant decrease in cell viability (to 50.9%) was observed after the combined treatment of 15 µM carnosic acid plus 4 µM arsenic trioxide in comparison with both the carnosic acid alone and the arsenic trioxide alone (P < 0.05).
CELL CYCLE PROGRESSION AND P27 EXPRESSION
Compared with untreated controls (35.7%), carnosic acid treatment (10 -20 µM) resulted in a significant increase (48.0 -57.9%) in the proportion of cells in the G 1 phase at 48 h (P < 0.05; Fig. 3A) . After 48 h of treatment, 15 µM carnosic acid and 4 µM arsenic trioxide resulted in 49.7% and 53.8% of cells in the G 1 phase, respectively. Carnosic acid plus arsenic trioxide resulted in a significantly pronounced increase (76.4%) in the proportion of cells in the G 1 phase compared with carnosic acid alone and arsenic trioxide alone (P < 0.05).
The results of the Western blot analysis (Fig.  4A) , show that carnosic acid elevated protein expression of the cyclin-dependent kinase (CDK) inhibitor p27 and strongly enhanced the level induced by arsenic trioxide; thus indicating p27 to be involved in carnosic acidinduced G 1 phase arrest in HL-60 cells.
APOPTOSIS AND EXPRESSION OF CLEAVED CASPASE-9
There was a significant increase (3.9 -13.9%) in apoptotic cells after carnosic acid exposure (10 -20 µM) compared with the control (0.14%) (P < 0.05; Fig. 3B) . Furthermore, the combination of carnosic acid (15 µM) plus arsenic trioxide (4 µM) significantly increased the proportion of apoptotic cells (77.9%) in comparison with carnosic acid (15 µM) alone (7.3%) and arsenic trioxide (4 µM) alone (41.1%) (P < 0.05; Fig. 3B) .
Results of the quantitative TUNEL assay show that carnosic acid caused a concentration-dependent increase in the amounts of fragmented DNA (Fig. 5A) and, in particular, significantly increased the amount of DNA fragmentation from 40.6% induced by arsenic trioxide alone to 72.7% when it was used in combination with arsenic trioxide (P < 0.05; Fig. 5B ).
Western blot analysis (Fig. 4A) showed that carnosic acid alone slightly increased the protein level of cleaved caspase-9 compared with the control, whereas a much greater increase was observed for the HL-60 cells treated with the carnosic acid plus arsenic trioxide combination.
EFFECTS ON PTEN
The level of protein and gene expression of PTEN in the HL-60 cells by Western blot and R Wang, H Li, G Guo et al. Figs 4A and 4B, respectively. In untreated (control) HL-60 cells there was no PTEN protein expression, whereas obvious expression was detected in HL-60 cells after incubation with carnosic acid (Fig. 4A) . Moreover, expression was markedly higher in the HL-60 cells after 48 h of culture with the carnosic acid plus arsenic trioxide combination than in the HL-60 cells after 48 h of culture with arsenic trioxide alone. In addition, as shown in Fig. 4B , the level of PTEN mRNA was concordant with the protein level.
Carnosic acid/arsenic trioxide in leukaemia cell apoptosis
RT-PCR analysis are shown in
Discussion
The search for new chemopreventive and antitumour agents that are more effective and less toxic has kindled great interest in phytochemicals. Natural products are an important source of potential chemotherapeutic agents. 12 Recently, carnosic acid has shown a variety of pharmacological activities for cancer chemoprevention in vitro and in vivo. In the current report, our results indicate that carnosic acid mediated apoptosis and induced G 1 phase block. They also showed that carnosic acid markedly decreased the viability of HL-60 myeloid cells at 15 -25 µM, although lower concentrations appeared to have little effect. More importantly, carnosic acid significantly augmented the G 1 arrest and apoptosis induced by a low concentration (4 µM) of arsenic trioxide.
Apoptosis represents a universal and exquisitely efficient suicide pathway, that is 
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considered an ideal way of eliminating damaged cells. 13 Thus, the induction of apoptosis is regarded as a possible mechanism for chemopreventive agents. The activation of caspases is a hallmark of apoptosis and the current findings demonstrated that the apoptosis induced by carnosic acid was correlated, at least in part, with activation of caspase-9. Apoptosis induction is highly correlated with the activation of a variety of intracellular signalling pathways leading to cell cycle arrest. 13 This is consistent with the G 1 arrest of the HL-60 cells induced by carnosic acid. The G 1 phase of the cell cycle is tightly regulated by the synthesis and degradation of cyclins, CDK and CDK inhibitors (CDKI). 14 We know that p27 is a CDKI, which acts as a key regulator of G 1 /G 0 accumulation and our results have shown that the upregulation of p27 is one of the molecular mechanisms by which carnosic acid induces G 1 arrest.
Studies suggest that PTEN expression at a physiological level suppresses cell growth, induces apoptosis, decreases cell size and renders the cells more susceptible to apoptotic stimuli, but that PTEN loss contributes to carcinogenesis. 15 As a tumour suppressor, PTEN controls at least two known cellular proto-oncogenes, that for phosphoinositide 3-kinase (PI3K) and that for Akt. Akt is likely to send survival signals by phosphorylating multiple targets, including the cell death pathway enzyme, caspase-9, and the CDK inhibitor, p27, and in this way protects cells from death and inhibits apoptosis. 16 Here we found that the HL-60 cells expressed a low level of PTEN mRNA and an extremely low level of, or no, PTEN protein, which agrees with reports by others. 17 Carnosic acid alone and combination of carnosic acid plus arsenic trioxide enhanced the levels of both PTEN protein and mRNA in HL-60 cells.
Arsenic trioxide has proven to be very effective in obtaining high clinically complete remission rates in leukaemia, however, its reported chronic toxicities and carcinogenicity have hampered its acceptance as a first-choice drug. 3 The major clinical limitation is a pronounced toxicity, which is dose dependent. One approach to overcoming this problem is combination therapy, which may allow for administration of lower doses of arsenic trioxide, thus minimizing toxicity and potential drug antagonism. 4 For example, the combination of all-trans-retinoic acid (ATRA) and a low concentration of arsenic trioxide has been reported to accelerate an antileukaemia effect by enhancing both differentiation and apoptosis in some models in vivo. 4 Nevertheless, ATRA has several serious clinical side effects on its own. On the other hand, carnosic acid, the major antioxidant of rosemary, has been proven to be non-toxic for human use and is widely used commercially for food protection and, therefore, appears to be safe for human administration. 8 Overall, carnosic acid induced G 1 arrest and apoptosis in HL-60 cells and, furthermore, this polyphenol considerably augmented these effects when induced by a low concentration of arsenic trioxide. These effects were associated with upregulation of p27 and activation of caspase-9, apparently mediated by inducing PTEN expression. Whether carnosic acid has the same effects in other leukaemia cells or in vivo remains to be investigated in future studies. However our data provide evidence that carnosic acid may have potential as an adjuvant in arsenic trioxide-induced apoptosis therapy due to its anticipated safety and great potency in enhancing the apoptosis-inducing action of low concentrations of arsenic trioxide. PTEN has an important role in the coordinated induction of apoptosis and G 1 arrest by carnosic acid plus arsenic trioxide.
